Professional Experiences

Turned complex payer, EMR, and claims data into strategic insights that drove a 15–20% improvement in market access efficiency, physician engagement, and patient journey optimization.
Led enterprise-wide Master Data Management (MDM) initiatives, unifying fragmented datasets into a single source of truth, reducing data reconciliation time by 30% and accelerating evidence-based commercial decision-making.
Designed and deployed Commercial Data Warehouse (CDW) solutions, enabling advanced analytics and actionable intelligence that supported decision-making for rare disease, autoimmune, and specialty therapy clients.
Advised clients on high-impact, data-driven go-to-market strategies, leveraging real-world evidence and payer analytics to increase patient access by 10–15% and optimize commercial outcomes.

Leveraged enterprise-scale data pipelines (PI RESTful APIs, AWS S3 DataLake) to extract and analyze high-volume process data using SQL and Python, uncovering actionable insights to enhance manufacturing reliability.
Applied machine learning techniques—including k-means clustering and anomaly detection—to identify predictive patterns in valve system performance, enabling proactive risk mitigation during equipment start-up.
Developed and deployed a real-time monitoring tool in Dataiku and Power BI under agile workflows (Jira), reducing downtime, product loss, and maintenance costs by flagging at-risk valves before failure.
Accelerated Gardasil 9 process validation milestones by leading exception report authoring in eVal and coordinating cross-functional review, ensuring compliance and timely execution of performance qualification deliverables.

Applied advanced R analytics (Seurat) to identify immune cell clusters and gene signatures from bulk and single-cell RNA-seq datasets of dermatomyositis patients, uncovering novel transcriptional patterns linked to disease pathology.
Developed and deployed an interactive RShiny dashboard to visualize systemic sclerosis scRNA-seq data post-Seurat processing, improving analytical accessibility and driving 40% faster insight generation for discovery scientists.
Optimized antibody–drug conjugate (ADC) potency assays by refining cell-surface antigen quantification via flow cytometry, enhancing data precision by 20% and strengthening preclinical decision-making.

Investigated how TDP-43 dysfunction generates cryptic neoantigens driving CD8⁺ T-cell–mediated pathology in ALS and IBM, integrating immunology, genomics, and bioinformatics to reveal a new adaptive immune axis.
Designed and executed a high-throughput TCR discovery and validation pipeline, cloning and transducing antigen-specific receptors to confirm neoantigen-driven, MHC I-restricted cytotoxicity in engineered cell models.
Optimized and conducted multi-color flow cytometry and live-cell assays to quantify T-cell activation, phenotype differentiation, and functional killing, enabling single-cell resolution mapping of immune responses.

Analyzed Southeast Asia’s $30B green building market to identify ESG and sustainability trends, informing GreenViet’s expansion into new service verticals.
Built business cases for Environmental Product Declarations (EPD) and Carbon Offset services, projecting $5M in first-year revenue and strengthening GreenViet’s strategic positioning in ESG consulting.
Developed forecasting models integrating market growth, policy shifts, and client demand to evaluate long-term profitability and scalability of new offerings.
Presented insights on carbon offset market potential, highlighting 1,500% forecasted demand growth and driving leadership buy-in for service diversification.

Interest Exploration & Career Development

Helped size a market and identify the competitive landscape for a large pharmaceutical company in key diseases in the area of hematology
Presented to panels, interviewed Key Opinion Leaders (KOLs), and conducted primary research to gather insights and data

Managed outreach to important figures in the biotech space to be interviewed for a podcast
Edited and published a podcast discussing current, important biotech topics

Crafted weekly articles for publication online and in print for the University of Pennsylvania cultural and fine-arts magazine
Managed Facebook and Instagram outreach to an audience of 2000+ followers